Pharma.AI Spring Kickoff 2026: Advancing the Future of Pharmaceutical Intelligence
As artificial intelligence continues to redefine the landscape of scientific innovation, its intersection with pharmaceutical research stands as one of ...
Tag: Insilico Medicine Pharma.AI platform
Insilico Medicine Names ISM6200 as a Promising Best-in-Class Selective NR3C1 Inhibitor for Ovarian Cancer, Cushing’s Syndrome, Obesity Linked to Hypercortisolism, and Glaucoma
In a groundbreaking stride forward in the realm of therapeutic innovation, Insilico Medicine, a clinical-stage company harnessing the power of ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!